Table 2.
Baseline characteristics of patients on ART at ART initiation in health facilities, Thyolo-Malawi
| Hospital | Health centres | Total | |
|---|---|---|---|
|
Total patients on ART |
8902 (74%) |
3102 (26%) |
12004 |
|
Gender |
|
|
|
| Male |
3354 (38%) |
962 (31%) |
4316 (36%) |
| Female |
5548 (62%) |
2140 (69%) |
7688 (64%) |
|
Median age – IQR |
34 (29–41) |
35 (29–42) |
35 (29–41) |
|
WHO stage / CD4 |
|
|
|
| WHO Stage 1–2 & CD4>200/mm3 |
193 (2%) |
18 (0.6%) |
211 (2%) |
| WHO stage 1–2 & CD4≤200/mm3 |
645 (7%) |
31 (1%) |
676 (6%) |
| WHO stage 1–2 & CD4 unknown |
192 (2%) |
139 (4%) |
331 (3%) |
| Stage 3† |
5581 (63%) |
2522 (81%) |
8103 (68%) |
| Stage 4† |
2291 (26%) |
392 (13%) |
2683 (22%) |
|
Start year of ART |
|
|
|
| 2003 |
391 (100%) |
NA |
391 |
| 2004 |
1058 (100%) |
NA |
1058 |
| 2005 |
1439 (100%) |
NA |
1439 |
| 2006 |
2281 (83%) |
451 (17%) |
2732 |
| 2007 |
2225 (62%) |
1347 (38%) |
3572 |
| 2008 | 1508 (54%) | 1304 (46%) | 2812 |
† Irrespective of CD4 count.
* CD4 counts were not reported separately as 68% of patients followed up in the health centres did not have CD4 counts. These are no longer done on WHO stage 3 and 4 patients, according to the Malawian guidelines.